Beginning with animal models, a streptozotocin (STZ)-induced mouse model of diabetes (STZ-DM) showed increased PKCα immunoreactivity in renal glomeruli and interstitial capillaries, cardiac capillaries, skeletal muscle capillaries, and large artery endothelial cells (33). Here, PRKCA is linked to diabetes mellitus.